Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...

Around half of study participants, all age 65 or younger, wouldn’t have been eligible for statins if they’d sought care 2 days earlier.

PCSK9 inhibitor therapy is less likely to be utilized in Black, Hispanic, and low-income patients hospitalized with ...

Factors linked to heart problems, such as high blood pressure, diabetes and bad cholesterol levels, can start years, ...

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial ...

Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have ...

When comparing atherosclerotic cardiovascular disease (ASCVD) with cancer, patients with both diseases appeared to have the greatest risk of experiencing financial toxicity. Financial toxicity is ...

Patients with depression may develop atherosclerotic cardiovascular disease earlier and start treatment more often than those ...

Early onset of menopause is an important risk factor for atherosclerotic cardiovascular disease (ASCVD), according to an analysis of women enrolled in numerous population-based studies. “To me, what ...

Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...

Mount Sinai study shows that traditional risk scores and symptoms such as chest pain should not be solely relied upon to ...